Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity

Abdul Aziz Timbilla, Filip Pidany, Eliska Kohelova, Jana Kroustkova, Karel Kralovec, Jan Rataj, Martina Ceckova, Negar Maafi, Víctor Lopez, Cristina Moliner Langa, Stefan Kosturko, Jaroslav Jenco, Darina Muthna, Darja Koutova, Martina Rezacova, Lucie Cahlikova, Jakub Chlebek, Radim Havelek

Open source

DOI: 10.1002/ardp.70197
Published: 2026-02
Container: Archiv der Pharmazie
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ardp.70197,
  title = {Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity},
  author = {Abdul Aziz Timbilla and Filip Pidany and Eliska Kohelova and Jana Kroustkova and Karel Kralovec and Jan Rataj and Martina Ceckova and Negar Maafi and Víctor Lopez and Cristina Moliner Langa and Stefan Kosturko and Jaroslav Jenco and Darina Muthna and Darja Koutova and Martina Rezacova and Lucie Cahlikova and Jakub Chlebek and Radim Havelek},
  year = {2026},
  journal = {Archiv der Pharmazie},
  doi = {10.1002/ardp.70197},
  url = {https://doi.org/10.1002/ardp.70197}
}

RIS

TY  - JOUR
TI  - Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity
AU  - Abdul Aziz Timbilla
AU  - Filip Pidany
AU  - Eliska Kohelova
AU  - Jana Kroustkova
AU  - Karel Kralovec
AU  - Jan Rataj
AU  - Martina Ceckova
AU  - Negar Maafi
AU  - Víctor Lopez
AU  - Cristina Moliner Langa
AU  - Stefan Kosturko
AU  - Jaroslav Jenco
AU  - Darina Muthna
AU  - Darja Koutova
AU  - Martina Rezacova
AU  - Lucie Cahlikova
AU  - Jakub Chlebek
AU  - Radim Havelek
PY  - 2026
JO  - Archiv der Pharmazie
DO  - 10.1002/ardp.70197
UR  - https://doi.org/10.1002/ardp.70197
ER  -

APA

Timbilla, A. A., Pidany, F., Kohelova, E., Kroustkova, J., Kralovec, K., Rataj, J., Ceckova, M., Maafi, N., Lopez, V., Langa, C. M., Kosturko, S., Jenco, J., Muthna, D., Koutova, D., Rezacova, M., Cahlikova, L., Chlebek, J., & Havelek, R. (2026). Harmine Derivatives as Anticancer Agents Endowed With Potent and Selective Antileukemia Activity: Synthesis, Biological Evaluation, Proapoptotic and Genotoxic Activity. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70197

Source records

crossref · retrieved 2026-11-08T16:21:11.972Z